{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:50:49Z","timestamp":1790380249270,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.eprac.2024.09.014","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T20:37:46Z","timestamp":1727296666000},"page":"1212-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiovascular Disorders Associated With Acromegaly: an Update"],"prefix":"10.1016","volume":"30","author":[{"given":"Rinsha P.V.","family":"Sherin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole O.","family":"Vietor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqueel","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-5604","authenticated-orcid":false,"given":"Thanh D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.M.","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib1","article-title":"Cardiovascular system changes and related risk factors in acromegaly patients: a case-control study","volume":"2015","author":"Guo","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984","volume":"223","author":"Bengtsson","year":"1988","journal-title":"Acta Med Scand"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2265.2008.03221.x","article-title":"High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels","volume":"69","author":"Schneider","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11102-010-0281-0","article-title":"Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population","volume":"14","author":"Rosario","year":"2011","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-21-0216","article-title":"Global epidemiology of acromegaly: a systematic review and meta-analysis","volume":"185","author":"Crisafulli","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2024.09.014_bib7","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1530\/eje.0.151s093","article-title":"The heart: an end-organ of GH action","volume":"151","author":"Colao","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.014_bib8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.CIR.87.5.1715","article-title":"Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes","volume":"87","author":"Ito","year":"1993","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2265.2003.01780.x","article-title":"Growth hormone, acromegaly, and heart failure: an intricate triangulation","volume":"59","author":"Sacc\u00e0","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0008-6363(98)00144-8","article-title":"Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c","volume":"39","author":"Hasdai","year":"1998","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/jc.2003-030967","article-title":"The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study","volume":"89","author":"Laughlin","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.hfc.2019.03.001","article-title":"Acromegaly and heart failure","volume":"15","author":"Colao","year":"2019","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.eprac.2024.09.014_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fendo.2020.00418","article-title":"Left heart dysfunction in acromegaly revealed by novel echocardiographic methods","volume":"11","author":"Uzi\u0229b\u0142o-\u017byczkowska","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11154-020-09560-x","article-title":"Acromegaly, inflammation and cardiovascular disease: a review","volume":"21","author":"Wolters","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.014_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP161637.OR","article-title":"Assessment of diastolic dysfunction, arterial stiffness, and carotid intima-media thickness in patients with acromegaly","volume":"23","author":"Cansu","year":"2017","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.014_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.eprac.2024.09.014_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fpubh.2020.00147","article-title":"New epidemiological, clinical and economic data for patients with acromegaly in Bulgaria","volume":"8","author":"Kamusheva","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.eprac.2024.09.014_bib18","article-title":"Advances in research on the cardiovascular complications of acromegaly","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12020-016-1191-3","article-title":"Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management","volume":"55","author":"Ramos-Lev\u00ed","year":"2017","journal-title":"Endocrine"},{"issue":"3-4","key":"10.1016\/j.eprac.2024.09.014_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ando.2020.03.010","article-title":"Cardiovascular complications of acromegaly","volume":"82","author":"Kamenick\u00fd","year":"2021","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.014_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1530\/EJE-11-0408","article-title":"Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study","volume":"165","author":"Colao","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib23","article-title":"Cardiac abnormalities in acromegaly patients: a cardiac magnetic resonance study","volume":"2020","author":"Guo","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2024.09.014_bib24","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1210\/jc.2015-2675","article-title":"Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort","volume":"100","author":"dos Santos Silva","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.014_bib26","first-page":"1086","article-title":"American Society of Echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12020-022-03232-3","article-title":"Filling the gap between the heart and the body in acromegaly: a case-control study","volume":"79","author":"S\u00e1gov\u00e1","year":"2023","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4183\/aeb.2019.52","article-title":"Echocardiographic myocardial changes in acromegaly: a cross-sectional analysis in a tertiary center in Bulgaria","volume":"5","author":"Natchev","year":"2019","journal-title":"Acta Endocrinol (Buchar)"},{"key":"10.1016\/j.eprac.2024.09.014_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jocn.2017.10.067","article-title":"Risk of left ventricular hypertrophy and diastolic and systolic dysfunction in acromegaly: a meta-analysis","volume":"48","author":"Guo","year":"2018","journal-title":"J\u00a0Clin Neurosci"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/14.1.26","article-title":"Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study","volume":"14","author":"Fazio","year":"1993","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.014_bib31","first-page":"513","article-title":"[Growth hormone and the heart]","volume":"38","author":"Fazio","year":"1993","journal-title":"Cardiologia"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib32","article-title":"Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease","volume":"2018","author":"Popielarz-Grygalewicz","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.eprac.2024.09.014_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.812964","article-title":"Subclinical ventricular dysfunction in long-term acromegaly assessed by speckle-tracking echocardiography","volume":"13","author":"Gadelha","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/qims.2020.02.05","article-title":"The right atrium in acromegaly-a three-dimensional speckle-tracking echocardiographic analysis from the MAGYAR-Path Study","volume":"10","author":"Korm\u00e1nyos","year":"2020","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib35","first-page":"634","article-title":"Subclinical left atrial and ventricular dysfunction in acromegaly patients: a speckle tracking echocardiography study","volume":"118","author":"Koca","year":"2022","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4103\/2230-8210.103007","article-title":"Congestive heart failure in acromegaly: a review of 6 cases","volume":"16","author":"Dutta","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11102-015-0655-4","article-title":"The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013","volume":"18","author":"Hoskuldsdottir","year":"2015","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.014_bib38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1507\/endocrj.EJ20-0129","article-title":"Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database","volume":"67","author":"Matsubayashi","year":"2020","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/clc.22867","article-title":"Acromegalic cardiomyopathy: epidemiology, diagnosis, and management","volume":"41","author":"Sharma","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.eprac.2024.09.014_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fendo.2019.00120","article-title":"Bringing cardiovascular comorbidities in acromegaly to an update. How should we diagnose and manage them?","volume":"10","author":"Ramos-Lev\u00ed","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.014_bib41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9343(02)01094-X","article-title":"High output heart failure in patients with newly diagnosed acromegaly","volume":"112","author":"Damjanovic","year":"2002","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.eprac.2024.09.014_bib42","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1210\/jc.2004-0821","article-title":"Long-term outcome of patients with acromegaly and congestive heart failure","volume":"89","author":"Bihan","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib43","doi-asserted-by":"crossref","first-page":"e1815","DOI":"10.1210\/clinem\/dgz317","article-title":"Risk for acromegaly-related comorbidities by sex in Korean acromegaly","volume":"105","author":"Park","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.eprac.2024.09.014_bib44","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/eurheartj\/ehab822","article-title":"Acromegaly and cardiovascular outcomes: a cohort study","volume":"43","author":"Hong","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.014_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/edrv-15-5-555","article-title":"Growth hormone and the heart","volume":"15","author":"Sacc\u00e0","year":"1994","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jc.2003-030849","article-title":"Increased prevalence of regurgitant valvular heart disease in acromegaly","volume":"89","author":"Pereira","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2024.09.014_bib49","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1210\/jc.2002-021099","article-title":"High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study","volume":"88","author":"Colao","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ghir.2006.02.002","article-title":"Uncontrolled acromegaly is associated with progressive mitral valvular regurgitation","volume":"16","author":"van der Klaauw","year":"2006","journal-title":"Growth Horm IGF Res"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.014_bib51","first-page":"7","article-title":"Progress in magnetic resonance research on heart disease in patients with acromegaly","volume":"47","author":"Guo","year":"2018","journal-title":"J\u00a0Med Res"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4183\/aeb.2018.365","article-title":"Cardiovascular complications of acromegaly","volume":"14","author":"Mizera","year":"2018","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.repc.2020.07.018","article-title":"Mitral annulus is dilated with preserved function in acromegaly regardless of its activity: insights from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study","volume":"40","author":"Nemes","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.repc.2021.02.006","article-title":"Mitral annular function in acromegaly: still a lot to learn","volume":"40","author":"Marta","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.014_bib55","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","article-title":"Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis","volume":"92","author":"Maison","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jc.2006-1587","article-title":"Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance","volume":"92","author":"Pivonello","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib57","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jc.2007-2199","article-title":"No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly","volume":"93","author":"Colao","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib58","doi-asserted-by":"crossref","first-page":"e937","DOI":"10.1210\/clinem\/dgz096","article-title":"A\u00a0consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0008-6363(99)00058-9","article-title":"Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes","volume":"43","author":"Kinugawa","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib60","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.eprac.2024.09.014_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2017.00129","article-title":"Increased short-term beat-to-beat QT interval variability in patients with impaired glucose tolerance","volume":"8","author":"Orosz","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2004.12.010","article-title":"Late potentials and ventricular arrhythmias in acromegaly","volume":"104","author":"Maffei","year":"2005","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.014_bib63","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1210\/jc.2013-4288","article-title":"Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea","volume":"99","author":"Chemla","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2024.09.014_bib64","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF03344070","article-title":"Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study","volume":"25","author":"Lombardi","year":"2002","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.014_bib65","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/00015385.2019.1610835","article-title":"Association between fragmented QRS and left ventricular dysfunction in acromegaly patients","volume":"75","author":"Dereli","year":"2020","journal-title":"Acta Cardiol"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib66","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12024-021-00361-5","article-title":"Undiagnosed acromegaly as an underlying cause of sudden death","volume":"17","author":"Borgen","year":"2021","journal-title":"Forensic Sci Med Pathol"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40618-020-01343-0","article-title":"Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?","volume":"44","author":"Parolin","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","article-title":"Growth hormone and the heart","volume":"54","author":"Colao","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.014_bib69","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1210\/jc.2005-2857","article-title":"Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography","volume":"91","author":"Cannavo","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.014_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-8703(80)90277-X","article-title":"Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients","volume":"100","author":"Lie","year":"1980","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib71","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2265.2000.01127.x","article-title":"Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction","volume":"53","author":"Maison","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.014_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/eje.0.1460303","article-title":"Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly","volume":"146","author":"Colao","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib73","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2265.2001.01281.x","article-title":"Characterization of premature atherosclerosis of carotid arteries in acromegalic patients","volume":"54","author":"Otsuki","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.eprac.2024.09.014_bib74","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1210\/jc.2007-1213","article-title":"Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study","volume":"92","author":"Bogazzi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.09.014_bib75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2017.12.019","article-title":"Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy","volume":"269","author":"Tellatin","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.eprac.2024.09.014_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2021.101442","article-title":"\u201cSubclinical atherosclerosis in acromegaly: possible association with cardiovascular risk factors rather than disease activity.\u201d","volume":"62","author":"de Almeida","year":"2022","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.014_bib77","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/08037050510034293","article-title":"Reduced nitric oxide levels in acromegaly: cardiovascular implications","volume":"14","author":"Ronconi","year":"2005","journal-title":"Blood Press"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib78","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s40618-023-02257-3","article-title":"Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy","volume":"47","author":"Arosio","year":"2024","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib79","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cen.15060","article-title":"Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-a retrospective analysis from the UK Acromegaly Register 1970-2016","volume":"100","author":"Orme","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib80","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/er.2018-00166","article-title":"Growth hormone's links to cancer","volume":"40","author":"Boguszewski","year":"2019","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.014_bib81","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-20-0019","article-title":"Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality","volume":"182","author":"Esposito","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.09.014_bib82","first-page":"53","article-title":"Patient perspectives on the impact of acromegaly: results from individual and group interviews","volume":"8","author":"Gurel","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.014_bib83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1071\/HC15033","article-title":"Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners","volume":"8","author":"Zarool-Hassan","year":"2016","journal-title":"J\u00a0Prim Health Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2400689X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2400689X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:38:57Z","timestamp":1733132337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2400689X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":83,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1530891X2400689X"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.09.014","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Disorders Associated With Acromegaly: an Update","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}